RCKT: Rocket Pharmaceuticals, Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 993.48
Enterprise Value ($M) 927.88
Book Value ($M) 463.23
Book Value / Share 3.16
Price / Book 3.01
NCAV ($M) 313.72
NCAV / Share 3.01
Price / NCAV 3.17

Profitability (mra)
Return on Invested Capital (ROIC) -0.73
Return on Assets (ROA) -0.46
Return on Equity (ROE) -0.48

Liquidity (mrq)
Quick Ratio 9.30
Current Ratio 6.05

Balance Sheet (mrq) ($M)
Current Assets 378.18
Assets 527.70
Liabilities 64.47
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income -273.20
Net Income -258.75
Earnings Per Share Basic And Diluted n/a

Cash Flow Statement (mra) ($M)
Cash From Operations -209.72
Cash from Investing 131.71
Cash from Financing 185.74

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)
Change
(%)
02-10 13G/A Wellington Management Group Llp 13.40 24.49
12-16 13D/A Rtw Investments, Lp 17.60
2024-02-13 13G/A Vanguard Group Inc 6.04 30.12
2024-01-29 13G/A BlackRock, Inc. 6.60 6.13

Top 13F Investors Shares
(1000)
Change
(%)
Value
($1000)
Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-02-27 198,814 871,231 22.82
2025-02-26 180,338 883,253 20.42
2025-02-25 305,455 1,805,589 16.92
2025-02-24 188,206 864,322 21.77

(click for more detail)

Similar Companies
QTTB – Q32 Bio Inc. RANI – Rani Therapeutics Holdings, Inc.
RAPT – RAPT Therapeutics, Inc. RLAY – Relay Therapeutics, Inc.
RNA – Avidity Biosciences, Inc.


Financial data and stock pages provided by
Fintel.io

Finpedia: Rocket Pharmaceuticals